Company
Raia Drogasil SA
Headquarters: Sao Paulo, SP, Brazil
Employees: 50,573
CEO: Mr. MarcÃlio D'Amigo Pousada
Market Cap
R$40.48 Billion
BRL as of Jan. 1, 2025
US$6.55 Billion
Raia Drogasil SA Categories
Brazil Healthcare Pharmaceutical RetailersBrazil Healthcare Brazil Pharmaceutical Retailers
Top Competitors by Market Capitalization
Industry: Pharmaceutical Retailers
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Detailed Description
Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. As of September 30, 2020, the company operated a network of 2,223 drug stores in 23 Brazilian states. It also markets its goods through telesales and its three call centers in the states of São Paulo and Tocantins. The company was founded in 1905 and is headquartered in São Paulo, Brazil.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Financials
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | R$37.70 B |
| EBITDA | R$3.55 B |
| Gross Profit TTM | R$10.21 B |
| Profit Margin | 2.95% |
| Operating Margin | 6.14% |
| Quarterly Revenue Growth | 15.10% |
Stocks & Indices
Raia Drogasil SA has the following listings and related stock indices.
Stock: Bovespa: RADL3 wb_incandescent
Stock: OTC: RADLY wb_incandescent